ENGLOBAL CORP: Nasdaq/NYSE listing notice — ENGlobal gets additional 180 days from Nasdaq to meet $1 minimum bid price

ENGLOBAL CORP

Nasdaq granted ENGlobal until December 18, 2023 to regain compliance with $1.00 minimum bid price.
Company failed to comply during initial 180-day grace period and now receives extension.
To cure, ENGlobal may implement a reverse stock split, must complete 10 business days before deadline.
If not compliant by Dec 18, Nasdaq may delist ENG; company can request a hearing.
Stock continues trading on Nasdaq Capital Market under symbol 'ENG' during extension.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

ENGLOBAL CORP received a nasdaq extension granted notice regarding minimum bid price (rules 5810(c)(3)(A)).

Exchange: nasdaq
Notice: extension granted
Deficiency: minimum bid price
Rules: 5810(c)(3)(A)

Exact text from the filing

June 27, 2023, ENGlobal Corporation (the “Company”) received notification from the Nasdaq Stock Market (“Nasdaq”) indicating that the Company will have an additional 180-day grace period, or until December 18, 2023, to regain compliance with Nasdaq's $1.00 minimum bid requirement. The notification indicated that the Company did not regain compliance during the initial 180-day grace period provided under the rule. In accordance with Nasdaq Marketplace Rule 5810(c)(3)(A), the Company is eligible for the additional grace period because it meets the continued listing requirement for market value o

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001654954-23-008528

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.